Texas Yale Capital Corp’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Texas Yale Capital Corp’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	11,525 -700	-6%	-$63.1K	0.02%	286
2026 Q1	$1.06M	Hold	12,225	–	–	0.03%	278
2025 Q4	$1.04M	Hold	12,225	–	–	0.03%	273
2025 Q3	$887K	Sell	12,225 -450	-4%	-$31K	0.03%	286
2025 Q2	$831K	Sell	12,675 -255	-2%	-$16.6K	0.03%	277
2025 Q1	$912K	Sell	12,930 -500	-4%	-$34.7K	0.04%	268
2024 Q4	$883K	Hold	13,430	–	–	0.04%	264
2024 Q3	$948K	Hold	13,430	–	–	0.04%	267
2024 Q2	$891K	Hold	13,430	–	–	0.04%	269
2024 Q1	$912K	Sell	13,430 -1,000	-7%	-$66.1K	0.04%	262
2023 Q4	$892K	Hold	14,430	–	–	0.04%	261
2023 Q3	$851K	Hold	14,430	–	–	0.04%	248
2023 Q2	$862K	Hold	14,430	–	–	0.04%	260
2023 Q1	$843K	Hold	14,430	–	–	0.04%	265
2022 Q4	$895K	Hold	14,430	–	–	0.05%	252
2022 Q3	$815K	Hold	14,430	–	–	0.05%	255
2022 Q2	$922K	Hold	14,430	–	–	0.06%	240
2022 Q1	$934K	Hold	14,430	–	–	0.05%	250
2021 Q4	$960K	Hold	14,430	–	–	0.05%	250
2021 Q3	$881K	Hold	14,430	–	–	0.05%	252
2021 Q2	$893K	Hold	14,430	–	–	0.05%	252
2021 Q1	$854K	Hold	14,430	–	–	0.05%	251
2020 Q4	$863K	Hold	14,430	–	–	0.06%	250
2020 Q3	$787K	Hold	14,430	–	–	0.06%	247
2020 Q2	$740K	Hold	14,430	–	–	0.06%	253
2020 Q1	$647K	Hold	14,430	–	–	0.06%	247
2019 Q4	$770K	Hold	14,430	–	–	0.05%	283
2019 Q3	$673K	Hold	14,430	–	–	0.05%	284
2019 Q2	$725K	Sell	14,430 -14,430	-50%	-$713K	0.05%	281
2019 Q1	$1.48M	Buy	28,860 +14,430	+100%	+$718K	0.06%	265
2018 Q4	$677K	Hold	14,430	–	–	0.06%	256
2018 Q3	$807K	Hold	14,430	–	–	0.07%	258
2018 Q2	$728K	Hold	14,430	–	–	0.06%	259
2018 Q1	$710K	Hold	14,430	–	–	0.06%	260
2017 Q4	$743K	Buy	14,430 +3,255	+29%	+$167K	0.06%	263
2017 Q3	$582K	Hold	11,175	–	–	0.05%	303
2017 Q2	$578K	Hold	11,175	–	–	0.05%	299
2017 Q1	$562K	Hold	11,175	–	–	0.05%	294
2016 Q4	$527K	Hold	11,175	–	–	0.05%	289
2016 Q3	$557K	Hold	11,175	–	–	0.05%	282
2016 Q2	$538K	Hold	11,175	–	–	0.05%	289
2016 Q1	$510K	Hold	11,175	–	–	0.05%	298
2015 Q4	$602K	Hold	11,175	–	–	0.06%	257
2015 Q3	$551K	Hold	11,175	–	–	0.05%	288
2015 Q2	$651K	Hold	11,175	–	–	0.05%	276
2015 Q1	$642K	Hold	11,175	–	–	0.05%	290
2014 Q4	$564K	Hold	11,175	–	–	0.05%	299
2014 Q3	$523K	Hold	11,175	–	–	0.05%	286
2014 Q2	$503K	Hold	11,175	–	–	0.06%	254
2014 Q1	$472K	Hold	11,175	–	–	0.07%	250
2013 Q4	$440K	Hold	11,175	–	–	0.07%	201
2013 Q3	$396K	Hold	11,175	–	–	0.07%	211
2013 Q2	$371K	Buy	+11,175	New	+$371K	0.06%	205

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Texas Yale Capital Corp's IHE Position: Q2 2026 in Review

Texas Yale Capital Corp reduced its iShares US Pharmaceuticals ETF (IHE) stake by 5.7% in Q2 2026, selling an estimated $63.1K and leaving 11,525 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #286.

Texas Yale Capital Corp first reported a position in IHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.48M in Q1 2019. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Texas Yale Capital Corp held 11,525 shares of iShares US Pharmaceuticals ETF worth $1.14M as of Q2 2026.
Texas Yale Capital Corp sold 700 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $63.1K.
iShares US Pharmaceuticals ETF made up 0.02% of Texas Yale Capital Corp's portfolio in Q2 2026, its #286 holding.
Texas Yale Capital Corp first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
Texas Yale Capital Corp's iShares US Pharmaceuticals ETF position peaked at $1.48M in Q1 2019.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.